268 results on '"Manns, Michael Peter"'
Search Results
2. Ex Vivo/In vivo Gene Editing in Hepatocytes Using “All-in-One” CRISPR-Adeno-Associated Virus Vectors with a Self-Linearizing Repair Template
3. Scent dog identification of SARS-CoV-2 infections in different body fluids
4. Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses
5. Defining virus-specific CD8+ TCR repertoires for therapeutic regeneration of T cells against chronic hepatitis E
6. Correction: Safety and efficacy of prophylactic and therapeutic vaccine based on live-attenuated Listeria monocytogenes in hepatobiliary cancers
7. The Third Signal Cytokine Interleukin 12 Rather Than Immune Checkpoint Inhibitors Contributes to the Functional Restoration of Hepatitis D Virus–Specific T Cells
8. Caspase 8 Small Interfering RNA Prevents Acute Liver Failure in Mice
9. Direct-Acting Antiviral–Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C
10. Scent dog identification of samples from COVID-19 patients – a pilot study
11. Canine real-time detection of SARS-CoV-2 infections in the context of a mass screening event
12. PD-1/CTLA-4 Blockade Leads to Expansion of CD8+PD-1int TILs and Results in Tumor Remission in Experimental Liver Cancer
13. Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls
14. PD-1/CTLA-4 Blockade Leads to Expansion of CD8+PD-1int TILs and Results in Tumor Remission in Experimental Liver Cancer.
15. Persistence of Occult Hepatitis B after Removal of the Hepatitis B Virus-Infected Liver
16. Discrimination of SARS-CoV-2 Infections From Other Viral Respiratory Infections by Scent Detection Dogs
17. Eradication of Chronic HCV Infection: Improvement of Dysbiosis Only in Patients Without Liver Cirrhosis
18. Additional file 1 of Scent dog identification of SARS-CoV-2 infections in different body fluids
19. Additional file 2 of Scent dog identification of SARS-CoV-2 infections in different body fluids
20. Additional file 3 of Scent dog identification of SARS-CoV-2 infections in different body fluids
21. Significant compartment‐specific impact of different RNA extraction methods and PCR assays on the sensitivity of hepatitis E virus detection
22. Scent dog identification of SARS-CoV-2 infections, similar across different body fluids
23. Epidemiology of fibrolamellar hepatocellular carcinoma in the USA, 2000–10
24. PD-1/CTLA-4 Blockade Leads to Expansion of CD8+PD-1intTILs and Results in Tumor Remission in Experimental Liver Cancer
25. IκBα gene therapy in tumor necrosis factor-α- and chemotherapy-mediated apoptosis of hepatocellular carcinomas
26. Changes in Plasma Amino Acids During Extracorporeal Liver Support by Fractionated Plasma Separation and Adsorption
27. Why Men Should Not Iron: Unperceived Swallowed Dental Root Instrument Causes Seven Years of Abdominal Pain
28. Cytochrome P450 enzymes and UDP-Glucuronosyltransferases as hepatocellular autoantigens
29. Video documented follow-up of liver transplantation in Wilsonʼs disease with predominant neurological manifestation
30. Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis
31. Doxycyline regulation in a single retroviral vector by an autoregulatory loop facilitates controlled gene expression in liver cells
32. Safety and efficacy of prophylactic and therapeutic vaccine based on live-attenuated Listeria monocytogenesin hepatobiliary cancers
33. Treatment of hepatitis B in special patient groups: hemodialysis, heart and renal transplant, fulminant hepatitis, hepatitis B virus reactivation
34. Autoantibodies in porphyria cutanea tarda: a controlled study
35. Hepatocellular Autoantigens
36. The impact of body composition analysis in HIV-infected patients: quantifying therapeutic effects
37. Autoimmunity and extrahepatic manifestations in hepatitis C virus infection
38. Supplementary table -Supplemental material for Long-term changes in liver elasticity in hepatitis C virus-infected patients with sustained virologic response after treatment with direct-acting antivirals
39. Hepatitis E Virus (HEV)-Specific T Cell Receptor Cross-Recognition: Implications for Immunotherapy
40. Sustained impact of nosocomial-acquired spontaneous bacterial peritonitis in different stages of decompensated liver cirrhosis
41. The impact of proton pump inhibitors on the intestinal microbiota in chronic hepatitis C patients
42. Necessity of educational programs for healthcare givers in preclinical settings of acute adrenal insufficiency in patients with chronic hypocortisolism
43. Concanavalin A-induced Liver Injury Triggers Hepatocyte Proliferation
44. Effect of glutamine-enriched total parenteral nutrition in patients with acute pancreatitis
45. Hepatitis B and C in HIV-infected patients : Prevalence and prognostic value
46. Differences in the regulation of cytochrome P450 family members during liver regeneration
47. Long‐term changes in liver elasticity in hepatitis C virus‐infected patients with sustained virologic response after treatment with direct‐acting antivirals
48. HCC Immune Surveillance and Antiviral Therapy of Hepatitis C Virus Infection
49. Transjugular diagnostics in acute liver failure including measurements of hepatocentral venous biomarker gradients
50. Travelling distance and support group participation in patients with chronic adrenal insufficiency
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.